Kadimastem: Hadassah approvals IRB for conducting a clinical trial in ALS Patients

Israeli biotechnology company Kadimastem has received approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for the phase I/IIa clinical trial...

Read more

Israël Science Info